Pulmonary Histoplasmosis

Carol A. Kauffman1

  • 1Division of Infectious Diseases, Veterans Affairs Healthcare System, 2215 Fuller Road, Ann Arbor, MI 48105. ckauff@umich.edu

Insights

Pulmonary histoplasmosis is usually mild but can be severe in immunocompromised individuals or those with COPD. Treatment depends on severity, ranging from itraconazole to amphotericin B.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Mycology

Background:

  • Pulmonary histoplasmosis is a fungal infection caused by Histoplasma capsulatum.
  • Most cases are self-limiting, but severe disease can occur.

Purpose of the Study:

  • To review the clinical presentation, complications, and treatment of pulmonary histoplasmosis.
  • To emphasize preventive measures for high-risk individuals.

Main Methods:

  • Literature review of pulmonary histoplasmosis.
  • Analysis of clinical manifestations and treatment outcomes.

Main Results:

  • Severe pneumonia can develop in immunocompromised patients or with high organism burden.
  • Chronic histoplasmosis is associated with severe COPD.
  • Mediastinal lymphadenopathy is a common complication.

Conclusions:

  • Mild to moderate cases are treated with itraconazole.
  • Severe cases require initial amphotericin B followed by itraconazole.
  • Preventive measures are crucial for occupational exposure.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
860
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
548